Previously-developed PCR protocols specific for the 16S rRNA gene of the intestinal spirochaetes Brachyspira aalborgi and Brachyspira pilosicoli were adapted for the detection of these species in human faeces, following DNA extraction and purification using mini-prep columns. The limits of detection in seeded faeces for B. aalborgi and B. pilosicoli respectively were 2U10 2 and 7U10 3 cells per PCR reaction, equivalent to 5U10 4 and 1U10 5 cells per g of faeces. The PCR techniques were applied to faecal samples from two patients with histological evidence of intestinal spirochaetosis. In the first patient, in whom B. aalborgi had been identified by 16S rDNA PCR from colonic biopsies, a positive amplification for B. aalborgi only was obtained from the faeces. The organism could not be isolated from these faeces. In the second patient, both colonic biopsies and faeces were PCR positive for B. pilosicoli only, and B. pilosicoli was isolated from the faeces. These new faecal PCR protocols should be valuable for future studies on the epidemiology of intestinal spirochaete infections in human populations, particularly as it is not currently possible to isolate B. aalborgi from faeces. ß
Introduction
Two species of anaerobic intestinal spirochaetes, Brachyspira (formerly Serpulina) pilosicoli [1] and Brachyspira aalborgi [2] , colonise the human large intestine [3, 4] . Both species are associated with a condition known as intestinal spirochaetosis (IS), in which a thin carpet-like layer of spirochaetes is found attached by one cell end to the colorectal surface epithelium [5] . Colonisation of humans by intestinal spirochaetes has been linked to a variety of intestinal disorders, including chronic diarrhoea and rectal bleeding [6] .
B. pilosicoli has been isolated from human faeces or intestinal biopsies in a number of studies from the USA [7] , Europe [8^10], Oman [11] , Papua New Guinea [12] , and Australia [3, 9, 13] . It also naturally infects pigs [1] , dogs [12] , and chickens [14] . In contrast, there are only two published reports of B. aalborgi being cultured^f rom rectal biopsy samples from ¢ve human patients in Denmark [2] , and a colonic biopsy from a Swedish patient [15] . B. aalborgi has never been isolated from faecal specimens. Speci¢c information about the prevalence of B. aalborgi came from studies using the polymerase chain reaction (PCR) on DNA extracted from colorectal biopsy samples. It was the most common of the two spirochaete species involved in IS in humans in Norway, the USA and Australia [4, 16] . Currently there is a lack of information about the distribution of B. aalborgi in human populations, directly related to the absence of reliable means to culture the spirochaete, and a lack of PCR or similar methods to detect the spirochaete in faeces.
The purpose of the current study was to develop PCR procedures for detecting B. aalborgi and B. pilosicoli in human faeces.
Materials and methods

Source of samples
Approval for this study was obtained from the Sir Charles Gardner Hospital and the Murdoch University Human Ethics Committees. Faecal samples were collected from two HIV-positive patients with histological evidence of IS in rectal and/or colonic biopsies, and in whom spirochaetes were observed in the faeces by phase contrast microscopy. In a previous study, PCR ampli¢cation of DNA extracted from para¤n embedded colonic biopsies showed that one of these patients (patient A) was colonised by B. aalborgi, and the other (patient B) by B. pilosicoli [16] . Three healthy volunteers also supplied faeces in which spirochaetes were not detected by either phase contrast microscopy or by selective culture.
Intestinal spirochaete strains
Two B. aalborgi strains and a single B. pilosicoli strain were obtained from the collection held at the Reference Centre for Intestinal Spirochaetes, Murdoch University, Western Australia. These were B. aalborgi type strain 513 T , a recent Swedish strain W1 provided by Dr C. Fellstro « m, and B. pilosicoli strain WesB, originally isolated from the faeces of an Australian Aboriginal child [13] . The spirochaetes were propagated anaerobically in an atmosphere of 94% N 2 and 6% CO 2 at 37³C on non-selective Trypticase soy agar containing 5% (v/v) de¢brinated sheep blood for 15 days. Viable cells were scraped from the agar and resuspended thoroughly in TE bu¡er (10 mM Tris^HCl, 1 mM EDTA, pH 8.0) to a concentration of 10 9 cells ml 31 .
Seeding of faeces with B. aalborgi and B. pilosicoli
The sensitivity of the faecal PCRs for B. aalborgi and B. pilosicoli was determined by seeding spirochaetes into faecal samples prior to extraction of chromosomal DNA. Sterile tubes containing either 0.1 or 0.2 g of faeces from three healthy individuals were each resuspended with 200 Wl serial 10-fold dilutions of spirochaete cells of either B. aalborgi strain 513 T or W1, or B. pilosicoli strain WesB in TE bu¡er ranging from 10 3 to 10 8 cells ml 31 . One tube consisting of 200 Wl of TE bu¡er was included as a negative control. These faecal suspensions were then immediately used for column extraction of chromosomal DNA and subsequently for the appropriate PCR.
Isolation of DNA
Chromosomal DNA was extracted and puri¢ed from the seeded faeces and the faeces of the two patients using a JETquick Tissue DNA Spin Column (Genomed GmH; Bad Oeynhausen, Germany) according to the manufacturer's instructions, with minor modi¢cations. Brie£y, sterile tubes containing 0.1 g of faeces were resuspended with 1 ml TE bu¡er. The tubes were vortexed for 5 min and centrifuged brie£y at 200Ug to pellet the large debris. The supernatant was transferred to a new sterile tube and the cells pelleted in a microfuge at 2500 rpm for 10 min before the supernatant was discarded. The pelleted cells were resuspended with 100 Wl of TE bu¡er and lysed by boiling for 5 min. 100 Wl of T2 or T2 substitute (4 M GuSCN, 100 mM Tris^HCl pH 7.5) was added to the lysed cells and incubated at 70³C for 10 min. The tube was allowed to cool at room temperature for 1 min before 100 Wl of absolute ethanol was added. The entire contents of the tube was applied to a spin column and centrifuged at 6000Ug for 1 min. The column was washed once with 500 Wl T3 at 6000Ug for 1 min and centrifuged at 14 000Ug for 2 min to remove any residual ethanol. Chromosomal DNA was eluted from the column at 6000Ug using 75 Wl of TE bu¡er heated to 70³C. The column eluate was reheated to 70³C and the elution step repeated. The ¢nal DNA solution was used for PCR ampli¢cation.
Polymerase chain reactions
A 471 base pair sequence of the 16S rRNA gene of B. aalborgi, equivalent to the base pair positions 172^675 of the 16S rRNA gene of Escherichia coli, was targeted for PCR ampli¢cation, as described previously [4] , except that dimethyl sulfoxide was not added. Furthermore, the 16S rRNA gene of B. pilosicoli was targeted for PCR ampli¢-cation as described previously [4] , except that a di¡erent reverse primer (5P-CCCCTACAATATCCAAGACT-3P) was used. This produced a 439 bp product equivalent to the base pair positions 204^676 of the 16S rRNA gene of E. coli [16] . For both PCR reactions, the ampli¢cation mixtures consisted of a 23 Wl reaction mix of 67 mM Tris^HCl (pH 8.8), 16.6 mM (NH 4 ) 2 SO 4 , 0.45% (v/v) Triton X-100, 0.2 mg ml 31 gelatin, 0.55 U of Tth Plus DNA polymerase (Biotech International Ltd; Bentley, WA, Australia), 1.5 mM of MgCl 2 , 5 nmol of each dNTP (Amersham Pharmacia Biotech AB; Uppsala, Sweden) and 12.5 pmol of each primer (F-Ba 16S and R-Ba 16S). An upper phase of 20 Wl of Chill-out 141 liquid wax (MJ Research Inc; Watertown, MA, USA) was added and allowed to solidify before the addition of 2 Wl puri¢ed DNA solution extracted from faeces. Cycling conditions involved a 2 min denaturing step at 94³C, followed by 33 cycles of denaturation at 94³C for 30 s, annealing at 46³C for 30 s, and a primer extension at 72³C for 30 s. The PCR products were subjected to electrophoresis in 1.5% (w/v) agarose gels in 1UTAE bu¡er (40 mM Tris^acetate, 1 mM EDTA), stained with ethidium bromide and viewed under UV light.
Culturing of faecal samples
The seeded faeces, and faecal samples from the two IS patients, were cultured on selective media based upon those described for the isolation of B. aalborgi [2] and B. pilosicoli [17] . Both used Trypticase soy agar (BBL) containing 5% de¢brinated ovine blood, with spectinomycin (400 Wg ml 31 ) and polymyxin (5 Wg ml 31 ) added for the isolation of B. aalborgi and spectinomycin (400 Wg ml 31 ), colistin (25 Wg ml 31 ) and vancomycin (25 Wg ml 31 ) added for the isolation of B. pilosicoli. The plates were incubated in anaerobic jars in an atmosphere of 94% N 2 and 6% CO 2 at 37³C for up to 21 days, and were examined for growth at weekly intervals.
Results
PCR on seeded faeces
The sensitivity obtained for the B. aalborgi speci¢c PCR, as applied to the B. aalborgi strains seeded into faeces from three healthy individuals, ranged from 5U10 4 to 5U10 7 per g of faeces. This was equivalent to a range of 2U10 2 to 2U10 3 cells per PCR reaction. The sensitivity obtained for the B. pilosicoli speci¢c PCR, as applied to the B. pilosicoli strain WesB seeded into faeces from the same three healthy individuals, ranged from 1U10 5 to 1U10 7 per g of faeces. This was equivalent to a range of 7U10 3 to 7U10 5 cells per PCR reaction.
Patient A
No spirochaetes were isolated from a faecal sample from patient A using the selective culture media, despite apparently viable spirochaete-like organisms being observed by phase contrast microscopy in that sample. However, positive ampli¢cation was obtained for the B. aalborgi speci¢c PCR from DNA extracted from the same faecal sample. No ampli¢cation was obtained from these DNA extracts when the B. pilosicoli speci¢c PCR was applied (Table 1) .
Patient B
Spirochaetes were cultured from the faecal sample taken from patient B, and were shown to be B. pilosicoli by PCR. DNA isolated from the faecal sample was only ampli¢ed in the PCR protocol speci¢c for the 16S rRNA gene of B. pilosicoli. No ampli¢cation was obtained from these DNA extracts when the B. aalborgi speci¢c PCR was applied (Table 1) .
Discussion
The described faecal PCR techniques were shown to detect either B. aalborgi or B. pilosicoli in faeces from patients with diagnosed cases of histological IS. The results correlated with the results of PCR on DNA extracted from colonic biopsies, and with faecal culture (in the case of B. pilosicoli). As anticipated, it was not possible to isolate B. aalborgi from the faeces ( Table 1) .
The use of spin columns for the extraction of bacterial DNA from faecal samples has been described previously [18] . Compared to the sensitivities obtained in that study, albeit for another species, the detection limits of 2U10 2 to 2U10 5 cells per reaction and 7U10 3 to 7U10 5 cells per reaction obtained in the current study for B. aalborgi and B. pilosicoli respectively were relatively poor, as well as being quite variable. Nevertheless these detection levels are comparable to those obtained by the selective culture of B. pilosicoli from pig faeces, and those obtained where PCR has been applied to primary spirochaetal growth on the isolation plate [19] . Consequently the technique described here should ¢nd application for direct detection of B. pilosicoli in faeces samples from humans, and probably also from infected animals. In the case of B. aalborgi, since this species has never been successfully isolated from faeces, the new faecal PCR technique should prove particularly valuable. Although detection limits were not as good as anticipated, modi¢cations such as the use of a nested PCR to the same DNA extraction method may increase the sensitivity of PCR detection.
The PCR techniques described here should prove useful in a diagnostic setting, for example in monitoring faecal shedding of B. aalborgi in patients with histological evidence of IS who are undergoing therapy for the condition. Furthermore the two PCR methods can now be used in prospective epidemiological studies in di¡erent populations, allowing the collection of important comparative data about the distribution and disease associations of these two anaerobic spirochaete species.
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